PAXLOVID, PFIZER’S ORAL COVID-19 PILL, APPROVED IN CANADA.
January 19, 2022
Pfizer’s Paxlovid COVID-19 antiviral pill has been approved for use in Canada.
Health Canada gave its approval on Monday, making Paxlovid the country’s first oral COVID-19 treatment that can be taken at home.
Paxlovid can be given to adults 18 and older who are positive for COVID-19 and are experiencing mild or moderate illness, and who are at high risk of becoming more seriously ill, Health Canada said.
Please CLICK HERE for this Global News media link.